Command Palette

Search for a command to run...

Clinical Trials · NCT02602600

Glucagon-like Peptide-1 and Coronary Microvascular Dysfunction in Women With Angina Pectoris and no Coronary Stenosis

CompletedPhase 4Liraglutide (Approved)
Phase
Phase 4
Recruitment status
Completed
Sponsor
Eva Prescott
Enrollment
33
Start date
Nov 2015
Locations
1 site, Denmark
Primary endpoint
Change from baseline in Coronary Flow Reserve
View Liraglutide compound reference